VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

S. 480 · 114th Congress

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 114th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

JSD ShaheenSponsor
12 cosponsors · 9 D, 3 R
SBD Brown RDD Durbin DFD Feinstein KGD Gillibrand EMD Markey JMD Manchin CSD Schumer JSR Sessions PTR Toomey EWD Warren RBD Blumenthal SCR Collins

10 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016

What it does: CRS summary · Reported to Senate with amendment(s) · Apr 27, 2016

National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016

(Sec. 3) This bill amends the Public Health Service Act to revise and extend through FY2021 the controlled substance monitoring program, including to:

  • allow grants to be used to maintain existing state controlled substance monitoring programs;
  • require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees;
  • require states to report on the interoperability of their programs with federal programs and health information technology systems and whether their programs provide automatic, up-to-date, or daily information about a patient upon request;
  • require states to provide HHS with aggregate data and other information to enable HHS to evaluate the success of state programs; and
  • expand the program to include any commonwealth or territory of the United States.

The Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a controlled substance monitoring database for research purposes may make that information available to other entities for research purposes.

HHS is no longer required to give preference for grants related to drug abuse to states with controlled substance monitoring programs.

A state receiving a grant for a controlled substance monitoring program must: (1) facilitate prescriber and dispenser use of the controlled substance monitoring system, and (2) educate prescribers and dispensers on the benefits of the system.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: National All Schedules Prescription Electronic Reporting Reauthorization Act of 2016

Latest action (Apr 27, 2016): Placed on Senate Legislative Calendar under General Orders. Calendar No. 440.

Policy area: Health · Origin: Senate · Introduced: Feb 12, 2015

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.